Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol

NCT03484611 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT03484611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03484611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol
Lead sponsor
Cairo University
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2013
Completion date
April 30, 2018
Enrollment
179 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

invitro fertilizaion